Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress. The results of the HealthCore, Inc. study, funded by Pamlab, L.L.C.
More information here
Related posts:
- R Albiglutide Improves Glucose Control And Reduces Weight Medical News Today New Phase II data presented at the American Diabetes Association...
- Ossulin Oral Insulin Data To Be Presented At The San Francisco Diabetes Congress On November 6 2009 The first public data on Ossulin™ a new oral insulin...
- Albiglutide Improves Glucose Control And Reduces Weight News Medical Net New Phase II data presented today at the American Diabetes...
- New Study Reports Weight Change Significantly Impacts Quality Of Life ForType 2 Diabetes Patients Type-2 diabetes patients who lose at least 5% of their...
- New Data Shows That Type 2 Diabetes Patients Who Start Insulin Vienna, Austria – Data from a new study presented today...